Study Highlights New Hope for Active Vitiligo Patients
A recent multicentre, randomised clinical trial aimed to evaluate the efficacy and safety of combining baricitinib, with narrowband UV-B phototherapy in adults with severe, active, nonsegmental vitiligo.